SearcharxivSearch

arXiv · 2505.06395

Contributions of the Petabyte Scale Sequence Search Codeathon toward efforts to scale sequence-based searches on SRA

Abstract

The volume of biological data being generated by the scientific community is growing exponentially, reflecting technological advances and research activities. The National Institutes of Health's (NIH) Sequence Read Archive (SRA), which is maintained by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM), is a rapidly growing public database that researchers use to drive scientific discovery across all domains of life. This increase in available data has great promise for pushing scientific discovery but also introduces new challenges that scientific communities need to address. As genomic datasets have grown in scale and diversity, a parade of new methods and associated software have been developed to address the challenges posed by this growth. These methodological advances are vital for maximally leveraging the power of next-generation sequencing (NGS) technologies. With the goal of laying a foundation for evaluation of methods for petabyte-scale sequence search, the Department of Energy (DOE) Office of Biological and Environmental Research (BER), the NIH Office of Data Science Strategy (ODSS), and NCBI held a virtual codeathon 'Petabyte Scale Sequence Search: Metagenomics Benchmarking Codeathon' on September 27 - Oct 1 2021, to evaluate emerging solutions in petabyte scale sequence search. The codeathon attracted experts from national laboratories, research institutions, and universities across the world to (a) develop benchmarking approaches to address challenges in conducting large-scale analyses of metagenomic data (which comprises approximately 20% of SRA), (b) identify potential applications that benefit from SRA-wide searches and the tools required to execute the search, and (c) produce community resources i.e. a public facing repository with information to rebuild and reproduce the problems addressed by each team challenge.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Priyanka Ghosh, Kjiersten Fagnan, Ryan Connor, Ravinder Pannu, Travis J. Wheeler, Mihai Pop, C. Titus Brown, Tessa Pierce-Ward, Rob Patro, Jacquelyn S. Michaelis, Thomas L. Madden, Christiam Camacho, Olaitan I. Awe, Arianna I. Krinos, René KM Xavier, Rodrigo Ortega Polo, Jack W. Roddy, Adelaide Rhodes, Alexander Sweeten, Adrian Viehweger, Bariş Ekim, Harihara Subrahmaniam Muralidharan, Amatur Rahman, Vinícius W. Salazar, Andrew Tritt, Thomas Colligan, Katrina Kalantar, Genevieve R. Krause, Taylor Reiter, George Lesica, Artem Babaian, Victor Lin, Sergey Madaminov, Vadim Zalunin, David M. Kristensen, Alexa Salsbury, Daniel P. Rice, J. Rodney Brister. 2025-05-09. Contributions of the Petabyte Scale Sequence Search Codeathon toward efforts to scale sequence-based searches on SRA. https://arxiv.org/abs/2505.06395

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT